Parametric Portfolio Associates’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,303
| Closed | -$201K | – | 4021 |
|
|
2018
Q3 | $201K | Buy |
+11,303
| New | +$201K | ﹤0.01% | 3762 |
|
|
2017
Q3 | – | Sell |
-90,620
| Closed | -$136K | – | 4080 |
|
|
2017
Q2 | $136K | Sell |
90,620
-71,709
| -44% | -$108K | ﹤0.01% | 3890 |
|
|
2017
Q1 | $417K | Buy |
162,329
+59,454
| +58% | +$153K | ﹤0.01% | 3279 |
|
|
2016
Q4 | $262K | Buy |
102,875
+73,667
| +252% | +$188K | ﹤0.01% | 3488 |
|
|
2016
Q3 | $90K | Buy |
29,208
+9,351
| +47% | +$28.8K | ﹤0.01% | 3691 |
|
|
2016
Q2 | $64K | Buy |
19,857
+4,592
| +30% | +$14.8K | ﹤0.01% | 3763 |
|
|
2016
Q1 | $47K | Buy |
+15,265
| New | +$47K | ﹤0.01% | 3927 |
|
|
2014
Q2 | – | Sell |
-10,864
| Closed | -$259K | – | 3836 |
|
|
2014
Q1 | $259K | Sell |
10,864
-3
| -0% | -$72 | ﹤0.01% | 3514 |
|
|
2013
Q4 | $116K | Sell |
10,867
-10,828
| -50% | -$116K | ﹤0.01% | 3709 |
|
|
2013
Q3 | $289K | Buy |
21,695
+8,853
| +69% | +$118K | ﹤0.01% | 3419 |
|
|
2013
Q2 | $169K | Buy |
+12,842
| New | +$169K | ﹤0.01% | 3508 |
|